Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Int J Obes (Lond). 2013 Nov 26;38(8):1068–1074. doi: 10.1038/ijo.2013.221

Table 2.

Summary of Functional Properties of Variant MC4Rs and Their Distribution in the Cohorts Studied

MC4R Construct Surface Expression Binding Signaling cAMP
Functional Category Pima Cohort Hispanic Cohort
Basal Stimulated
G55V + LOF 0 5a
R165G + + LOF 9 0
R165Q + LOF 19 0
C172R LOF 0 5a
F202L ND + + + NFA 0 3
M208V + LOF 0 1
I269N + + LOF 0 11
A303P + LOF 3 0

D37Stop LOFb 12 0
V103I + + + + GOFc 11 8
I251L + + + GOFc 9 12

Abbreviations: MC4R, melanocortin-4 receptor; cAMP, 3′-5′-cyclic adenosine monophosphate; LOF, loss-of-function; NFA, non-function-altering; GOF, gain-of-function; +, no significant difference compared with common MC4R, ND, not done.

a

One subject was compound heterozygous for G55V and C172R.

b

Nine subjects heterozygous, 3 subjects homozygous for this frameshift mutation that results in premature termination prior to the ligand binding domain. Decreased stimulated cAMP generation previously reported.16 Surface expression, ligand binding, and basal activity have not been reported.

c

Categorized as GOF because V103I previously reported to have decreased agouti-related peptide potency, while I251L has increased basal activity.17